tiprankstipranks
Kubota Pharmaceutical Holdings Co Ltd (KBBTF)
OTHER OTC:KBBTF
US Market

Kubota Pharmaceutical Holdings Co (KBBTF) Stock Price & Analysis

5 Followers

KBBTF Stock Chart & Stats

Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

KBBTF FAQ

What was Kubota Pharmaceutical Holdings Co Ltd’s price range in the past 12 months?
Currently, no data Available
What is Kubota Pharmaceutical Holdings Co Ltd’s market cap?
Currently, no data Available
When is Kubota Pharmaceutical Holdings Co Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kubota Pharmaceutical Holdings Co Ltd’s earnings last quarter?
Currently, no data Available
Is Kubota Pharmaceutical Holdings Co Ltd overvalued?
According to Wall Street analysts Kubota Pharmaceutical Holdings Co Ltd’s price is currently same. Get more investment ideas with TipRanks Premium
    Does Kubota Pharmaceutical Holdings Co Ltd pay dividends?
    Kubota Pharmaceutical Holdings Co Ltd does not currently pay dividends.
    What is Kubota Pharmaceutical Holdings Co Ltd’s EPS estimate?
    Kubota Pharmaceutical Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Kubota Pharmaceutical Holdings Co Ltd have?
    Currently, no data Available
    What happened to Kubota Pharmaceutical Holdings Co Ltd’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Kubota Pharmaceutical Holdings Co Ltd?
    Currently, no hedge funds are holding shares in KBBTF
    ---

    Kubota Pharmaceutical Holdings Co Stock Smart Score

    N/A
    Not Ranked
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Technicals

    SMA
    Positive
    20 days / 200 days
    Momentum
    0.00%
    12-Months-Change

    Fundamentals

    Return on Equity
    -40.06%
    Trailing 12-Months
    Asset Growth
    -27.64%
    Trailing 12-Months

    Company Description

    Kubota Pharmaceutical Holdings Co Ltd

    Kubota Pharmaceutical Holdings Co. Ltd. operates as a holding company which provides the management of its subsidiaries. The company is also involved in the developing patient based ophthalmology suite to detect nascent disease progression to enhance treatment outcome in patients with wet AMD (Age-related Macular Degeneration), DME (Diabetic Macular Edema) and other neovascular retinal diseases. It also provides the research, development, export, import, manufacture and sale of pharmaceutical products worldwide. The company was founded on December 11, 2015 and is headquartered in Tokyo, Japan.
    ---
    Similar Stocks
    Company
    Price & Change
    Follow
    Bayer
    Novo Nordisk
    Roche Holding
    Takeda Pharmaceutical Company
    Popular Stocks
    ---
    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis